Confronting the Crisis of Opioid Addiction: An Overview of Beacon s White Paper



Similar documents
Confronting the Crisis of Opioid Addiction: An Overview of Beacon s White Paper

Federal Response to Opioid Abuse Epidemic

Governor s Task Force on Mental Health and Substance Use.

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Reforming the Response To Substance Use: A Drug Policy for the 21 st Century

Testimony of The New York City Department of Health and Mental Hygiene. before the

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

Statement. of the. American Medical Association. to the

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health

Prescriber Behavior, Pain Treatment and Addiction Treatment

Jane Maxwell, UT Addiction Research Institute, Prescription Pain Medications and Heroin: A Changing Picture

A Drug Policy for the 21st Century

CONFRONTING THE CRISIS OF OPIOID ADDICTION A BEACON HEALTH OPTIONS WHITE PAPER

CONFRONTING THE CRISIS OF OPIOID ADDICTION A BEACON HEALTH OPTIONS WHITE PAPER

John R. Kasich, Governor Orman Hall, Director

1. THE OPIOID EPIDEMIC IN WISCONSIN ISSUE BRIEF

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Opioid/Opiate Dependent Pregnant Women

Joel Millard, DSW, LCSW Dave Felt, LCSW

8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Hulpverleningsmodellen bij opiaatverslaving. Frieda Matthys 6 juni 2013

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

National Perspectives in Medication Assisted Treatment

Substance Use Disorder Treatment: Challenges and the Future

Buprenorphine Therapy in Addiction Treatment

P U B L I C H E A L T H A D V I S O R Y

Opioid Treatment Services, Office-Based Opioid Treatment

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

A Drug Policy for the 21st Century. Office of National Drug Control Policy

Web-Based Resources. Locating Treatment

How To Treat Anorexic Addiction With Medication Assisted Treatment

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment

Congressional Testimony. Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry

Acronyms for the Prevention and Treatment of Substance Use Disorders. Prepared by Mental Health Legal Advisors Committee November 2015

The Changing Face of Opioid Addiction:

Effective Treatment Strategies for Adolescent Heroin and Opiate Use. Chris Gleason, MA, CAADC, MAATP Director Rosecrance McHenry County

Treatment Approaches for Drug Addiction

Treatment of opioid use disorders

Medication-Assisted Addiction Treatment

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Striking a Balance: a provider perspective. kpfeifer@chcf.org

FISCAL IMPACT STATEMENT. LS 7351 NOTE PREPARED: Feb 6, 2015 BILL NUMBER: SB 464 BILL AMENDED: Feb 5, 2015

Substance Use: Addressing Addiction and Emerging Issues

1) What would it take to get four or five FQHCs to implement ECHO, and how many patients can we serve?

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Substance Use Disorder Treatment in Los Angeles: The Past, Present, and Future

Treatment Approaches for Drug Addiction

TESTIMONY. March 17, Rutland, VT

Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation

King County Drug Trends 2015

Allyse Adams PC, LICDC Oriana House, Inc.

Travis Baggett, MD, MPH Jessie M. Gaeta, MD Jennifer Brody, MD, MPH Boston Health Care for the Homeless Program

CENTER FOR RURAL PA PUBLIC HEARING OPIATE ABUSE TREATMENT AND RECOVERY SERVICES. York, PA. August 18, 2015

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

Care Management Council submission date: August Contact Information

Office-based Treatment of Opioid Dependence with Buprenorphine

Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD

Behavioral Health Provider Implementation of Whole Health Integrative Treatment Services

Using Drugs to Treat Drug Addiction How it works and why it makes sense

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

Steps To Addiction Recovery Treatment

Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

Testimony on Addressing Heroin and Opioid Addiction. Theodore Dallas. Secretary, Department of Human Services. Center for Rural Pennsylvania

The Need for Medication-Assisted Treatment (MAT)

Prescription Drug Abuse: Recognition, Intervention, and Prevention

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community

The Determinations Report: A Report On the Physician Waiver Program Established by the. Drug Addiction Treatment Act of 2000 ( DATA )

Testimony Center for Rural Pennsylvania PUBLIC HEARING - Heroin and Opioid Addiction Treatment and Recovery Scranton, PA July 29, 2015

Treatment of Opioid Use Disorders in Jails and Prisons Why, When, and How

The ABCs of Medication Assisted Treatment

INSTRUCTIONS AND PROTOCOLS FOR THE IMPLEMENTATION OF MEDICATION-ASSISTED TREATMENT FOR OPIOID/OPIATE DEPENDENCE

Evidence Based Approaches to Addiction and Mental Illness Treatment for Adults

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Medication Assisted Treatment

MAT Disclosures & Consents 1 of 6. Authorization & Disclosure

Frequently asked questions

TREATMENT MODALITIES. May, 2013

Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Opioid Addiction & Corrections

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse

Use of Pharmacotherapies by Substance Abuse Treatment Facilities

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009

ARCHIVED BULLETIN. Product No L SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E

MEDICAL ASSISTANCE BULLETIN

Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County

Transcription:

Confronting the Crisis of Opioid Addiction: An Overview of Beacon s White Paper July 2, 2015 B. Steven Bentsen MD, DFAPA Board certified in Addiction Medicine

Opioid Addiction Is Headline News Why? There has been massive overprescribing of opioid painkillers Heroin abuse is growing Treatment is fragmented and hard to access Deaths from opioids outnumber deaths from motor vehicle accidents per annum 2

Drug-poisoning Deaths Involving Heroin: United States, 2000 2013 * 3

Issues Unique to Addiction Treatment Widest gap between science and clinical practice About 50 percent of family members would help a family member obtain treatment About 5 percent of treatment referrals are from health care providers Forty-four (44) percent of referrals from legal system Most do not receive best practice care Only minority of states monitor treatment outcomes Quality measures not standardized Many programs exempt from state regulation or medical oversight 4

Medication-assisted Treatment (MAT) Reduces All-cause Mortality Receiving treatment Untreated the all-cause mortality rate for patients receiving methadone maintenance treatment was similar to the mortality rate for the general population, whereas the mortality rate of untreated individuals using heroin was more than 15 times higher. Modesto-Lowe et al., 2010; Gibson, 2008; Mattick, 2003; Bell and Zador, 2000; Marsch, 1998 5

MAT as Part of Treatment Program Four approved medications for treatment of opiate dependency: Buprenorphine Methadone Naltrexone oral Naltrexone injectable MAT is an evidence-based treatment for opioid addiction; however, it is not a stand-alone treatment choice. MAT has proven to be very effective as part of a holistic, evidence-based treatment program that includes behavioral, cognitive and other recovery-oriented interventions, treatment agreements, urine toxicology screens and checking of PDMP. 6

Opioid Addiction: A Chronic Illness Should Be Treated Through Chronic Disease Model Recommended Interventions Increase community resources and policies Increase collaboration between payers and providers Improve access to resources for self - management Description Make naloxone widely available Remove barriers to non-acute provider capacity: Methadone, Suboxone Extenders - mid-level administrators under supervision Public awareness campaign targeting citizens, prescribers & policymakers about the chronic disease model Encourage bundled payments for high-quality providers to encourage community care instead of institutional care: Peers, office and home-based formats De-stigmatize long-term treatment options. More than just abstinence Promote verbal and written explanation of treatment options, alternatives, risks and benefits, including Medication-Assisted Therapies (MAT) Improve design of delivery system Increase decision support Re-unify the system of care (e.g. Department of Health carve-outs) in accordance with ASAM criteria Require case/care management/pain management services to be part of full-service addictions treatment Apply evidence-based clinical practice guidelines to MAT, including real time support for prescribers (e.g. expert staffed support hotline for prescribers treating addictions) Implement clinical information systems Registries Implement EHR technology to ensure real-time access to pertinent clinical information (i.e., diagnoses, co-morbidities, medications, treatment goals) Clear interpretation that SA-related personal health information will not be used for prosecutorial purposes 7

Summary 1. Prescription opioid addiction has reached crisis proportions. 2. Social bias and a pervasive view of addiction as a moral failing has limited access to effective, evidence-based treatments. 3. Implementing the six tenets of the chronic disease model of care signifies a major redesign of the current health care system to appropriately treat the chronic disease of opioid addiction and combat the opioid crisis. 4. As the path to addiction often begins with prescribed opioids for the treatment of pain, a comprehensive treatment continuum needs to include pain management. 5. Legislation could be instrumental in realizing this goal. 8

Thank you For questions submitquestions@beaconhealthoptions.com 9